- Home
- OSUR
as 07-26-2024 4:00pm EST
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | BETHLEHEM |
| Market Cap: | 290.7M | IPO Year: | 1986 |
| Target Price: | $6.50 | AVG Volume (30 days): | 828.2K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.30 | EPS Growth: | -25.00 |
| 52 Week Low/High: | $3.92 - $8.45 | Next Earning Date: | 08-06-2024 |
| Revenue: | $304,641,000 | Revenue Growth: | -35.83% |
| Revenue Growth (this year): | -52.91% | Revenue Growth (next year): | -13.77% |
Stock Insider Trading Activity of OraSure Technologies Inc. (OSUR)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Weber Kathleen Gallagher | OSUR | Chief Product Officer | Dec 19 '23 | Sell | $8.05 | 24,129 | $194,219.15 | 254,700 | SEC Form 4 |
Latest OraSure Technologies Inc. News
OSUR Breaking Stock News: Dive into OSUR Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
GlobeNewswire
a month ago
OraSure Technologies Supports National HIV Testing Day
Simply Wall St.
a month ago
The past three years for OraSure Technologies (NASDAQ:OSUR) investors has not been profitable
CNW Group
2 months ago
Lotto 6/49 - $64 million up for grabs in the next draw!
Simply Wall St.
2 months ago
Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
AFP
2 months ago
Seoul says it will resume loudspeaker propaganda against North
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
Simply Wall St.
2 months ago
OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
Compare OSUR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OSUR OraSure Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.